[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100448707":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":23,"responsibleParty":41,"collaborators":44,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":7,"enrollmentInfo":57,"targetDuration":7,"studyType":60,"phases":7,"briefSummary":61,"conditions":62,"keywords":7,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Mayo Clinic","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","Remote Heart Rhythm Monitoring","We will be looking to see if remote heart rhythm monitoring for 30 days at baseline, 12, and 24 months, helps for early identification of adverse cardiac events.",[14],{"name":15,"affiliation":5,"role":16},"Alexander Egbe, MBBS, MPH","PRINCIPAL_INVESTIGATOR",[18],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},"Halley Davison","CONTACT","507-422-6246","RSTACHDRESPRG@mayo.edu",[24],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Mayo Clinic in Rochester","RECRUITING","Rochester","Minnesota","55905","United States","US",{"type":33,"coordinates":34},"Point",[35,36],-92.4699,44.02163,{"lat":36,"lon":35},[39,40],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},{"name":15,"role":16,"phone":7,"phoneExt":7,"email":7},{"type":16,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Alexander C. Egbe","Principal Investigator",[45],{"name":46,"class":47},"National Heart, Lung, and Blood Institute (NHLBI)","NIH","100448707","pathophysiologic-mechanism-for-arrhythmias-and-impaired-aerobic-capacity-in-tetralogy-of-fallot-and-other-congenital-heart-diseases-100448707",false,"NCT05122962","Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases","PACT","Inclusion Criteria:\n\n* Moderate (or greater) PR based on quantitative Doppler echocardiography.\n* Repaired TOF\n* Congenital Heart Disease diagnosis including but not limited to Ebstein's anomaly, coarctation of the aorta (COA), Fontan palliation, transposition of the great arteries, congenitally corrected transposition of the great arteries.\n\nExclusion Criteria:\n\n* Pregnant Women\n* Unable to undergo CMRI","ALL","18 Years",{"count":58,"type":59},300,"ESTIMATED","OBSERVATIONAL","This study is being done to determine the mechanism(s) contributing to the onset of symptoms (i.e. shortness of breath and\u002For palpitations) as well as changes in heart structure in patients with congenital heart disease (CHD)",[63,64],"Tetralogy of Fallot","Congenital Heart Disease","2026-02-03",{"date":67,"type":68},"2026-02-05","ACTUAL",{"date":70,"type":68},"2021-11-01",{"date":72,"type":59},"2026-10",{"name":5,"class":6},1]